Trademark: EC-NAPROSYN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for EC-NAPROSYN
We do not have any records of a proof of use for EC-NAPROSYN at this moment.
Possible trademark infringements of EC-NAPROSYN
Basic Information about EC-NAPROSYN
- Serial Number
- 74401683
- Filing Date
- 14 Jun 1993
- Registration Number
- 1920670
- Registration Date
- 19 Sep 1995
- Mark Drawing Code
- 1
Classifications
Declare the trademark use of EC-NAPROSYN on the blockchain with WikiTrademarks.io.
- First use of EC-NAPROSYN anywhere
- EC-NAPROSYN was first used on 30 Dec 1994 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns EC-NAPROSYN?
1. ATNAHS PHARMA US LIMITED LONDON
2. ATNAHS PHARMA UK LTD LONDON
3. SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED Hamilton
4. SYNTEX PUERTO RICO, INC. Humacao PR
5. SYNTEX PUERTO RICO, INC. Humacao PR
6. SYNTEX PUERTO RICO, INC. Humacao PR
Correspondent
- William H. Needle Ballard Spahr LLP
- 999 Peachtree Street
- Suite 1000
- Atlanta, GA 30309
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io